Search results for: “oncology”
-
AQEMIA raises €60M to boost its AI-powered drug discovery platform and pipeline
•
AQEMIA, a tech-enabled drug discovery company that uses generative AI and deep physics to find new drugs, has…
-
Sanofi to buy Inhibrx for $1.7 billion
•
PARIS, FRANCE: Sanofi, a global pharmaceutical company, has agreed to acquire Inhibrx, a clinical-stage biotech firm, for $30.0…
-
Galapagos NV signs agreement to transfer Jyseleca business to Alfasigma
•
MECHELEN, BELGIUM: Galapagos NV and Alfasigma S.p.A. today announced that they have signed an agreement to transfer Galapagos’…
-
Bristol Myers Squibb to buy RayzeBio for $4.1 billion in cash
•
Bristol Myers Squibb (BMY), a leading biopharmaceutical company, announced today that it has agreed to acquire RayzeBio (RYZB),…
-
AstraZeneca to buy Gracell Biotechnologies for up to $1.2bn to boost cell therapy pipeline
•
Acquisition of Gracell completed AstraZeneca has agreed to acquire Gracell Biotechnologies, a company developing cell therapies for cancer…
-
Oxford Biomedica transforms into a pure-play CDMO in cell and gene therapy
•
LONDON, UK: Oxford Biomedica, a leading cell and gene therapy CDMO, has announced a business update for the…
-
Arecor signs co-development agreement with leading global medical products company
•
CAMBRIDGE, UK: Arecor Therapeutics plc announced a co-development and exclusive licence option agreement with a leading global medical…
-
Ariel Investments buys 58.5% stake in My Code at $400 million valuation
•
My Code, a company that provides solutions to brands that want to reach diverse audiences, has sold 58.5…
-
Johnson & Johnson MedTech acquires Laminar Inc. for an upfront $400 million
•
NEW BRUNSWICK: Johnson & Johnson MedTech, a division of Johnson & Johnson that focuses on medical intervention solutions,…
-
Sproutly nears Apollon Formularies acquisition, due diligence completed
•
LONDON, UK: Sproutly Canada and Apollon Formularies have announced the completion of their due diligence. Sproutly, a Canadian…
-
AstraZeneca’s Truqap approved in US for advanced breast cancer
•
LONDON: AstraZeneca announced that its drug Truqap (capivasertib) has received approval from the US Food and Drug Administration…
-
Starpharma Holdings appoints Cheryl Maley as Chief Executive Officer and Managing Director
•
MELBOURNE, AUSTRALIA: Starpharma Holdings (ASX: SPL) announced the appointment of Ms Cheryl Maley as Chief Executive Officer (CEO)…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.